Vitrolife logo

Vitrolife Stock

StockStock
ISIN: SE0011205202
Ticker: VITR
SE0011205202
VITR

Price

Historical dividends and forecast

All dividend data

Vitrolife has so far distributed $0.0927 in 2024. The next dividend will be paid on 03.05.2025


$0.0531

CHART BY

Frequently asked questions

What is Vitrolife's market capitalization?

The market capitalization of Vitrolife is $2.99B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Vitrolife?

Vitrolife's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.575. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Vitrolife's stock?

Currently, 3 analysts cover Vitrolife's stock, with a consensus target price of $20.96. Analyst ratings provide insights into the stock's expected performance.

What is Vitrolife's revenue over the trailing twelve months?

Over the trailing twelve months, Vitrolife reported a revenue of $325.67M.

What is the EBITDA for Vitrolife?

Vitrolife's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $109.69M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Vitrolife?

Vitrolife has a free cash flow of $47.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Vitrolife's stock?

The 5-year beta for Vitrolife is 2.12. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Vitrolife have, and what sector and industry does it belong to?

Vitrolife employs approximately 1,100 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Vitrolife's shares?

The free float of Vitrolife is 75.05M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$2.99B

5Y beta

 
2.12

EPS (TTM)

 
-$2.575

Free Float

 
75.05M

Revenue (TTM)

 
$325.67M

EBITDA (TTM)

 
$109.69M

Free Cashflow (TTM)

 
$47.65M

Pricing

1D span
$21.62$22.27
52W span
$14.45$26.45

Analyst Ratings

The price target is $20.96 and the stock is covered by 3 analysts.

Buy

2

Hold

1

Sell

0

Information

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

1,100

Biotechnology & Drugs

Health Care

Identifier

ISIN

SE0011205202

Primary Ticker

VITR

Knockouts

Join the conversation